Product Manager - 9 Intraoperative Technology
About the job
- Must have medical industry experience.
- A minimum of 2–4 years of related experience is required, or an equivalent combination of education and experience.
- A Bachelor's degree in Marketing or a related field is required.
- Knowledge of computer applications including Microsoft Word, Excel, PowerPoint, Access, Project, Windows, and Internet applications is required.
- Excellent oral and written communication skills are required.
- Superior interpersonal skills are required.
- Ability to organize and prioritize workflow and meet established timeframes.
- Ability to multitask within a cross-functional team and matrix management structure.
- Strong attention to detail is required.
- Ability to represent the company at a variety of business functions or situations in a professional and competent manner.
- Ability to exercise independent judgment consistent with department guidelines.
- Ability to maintain updated knowledge of procedures, products, and activities of the assigned product line.
- Ability to perform multiple tasks in a fast-paced team environment.
- Ability to work under pressure.
- Proven skill and experience in overall market analysis, planning, development, and management.
- Demonstrated strategic and tactical planning and implementation capabilities.
- Ability to prepare sales forecasts.
- Experience with and understanding of a clinical and surgical environment and workflow.
- Ability to travel up to 40 percent.
- Candidates must be authorized to work in the United States without current or future employer sponsorship.
- For United States roles requiring hospital access, candidates must be eligible for and maintain credentials at all required hospitals, including applicable physical or vaccination requirements.
- Identify and implement product strategies, marketing plans, promotional and advertising programs, and oversee product management for the assigned product line.
- Develop and implement product marketing campaigns, including objectives, short- and long-term strategies, market research, competition tracking, product mix, action plans, and return-on-investment analysis.
- Analyze market trends, company sales, and buyer behavior, and modify product strategies accordingly.
- Develop and present business cases to justify new products.
- Manage product marketing activities, including project management, market launch, and market surveillance.
- Pursue product line extensions or trimming, labeling revisions, clinical studies, and other activities that build and sustain product-line value and maximize earnings.
- Seek new innovations for the assigned product line.
- Develop sales collateral, customer service processes, and manufacturing operations that support the assigned product line.
- Develop and monitor sales forecasts and collaborate with other departments to optimize product mix throughout the product lifecycle.
- Monitor the competitive landscape by reviewing scientific literature and competitor product offerings, traveling with field sales personnel, attending surgeries, meeting stakeholders, and attending scientific meetings.
- Develop product presentations, surgical techniques, and white papers supporting sales and corporate marketing campaigns.
- Monitor product development progress and obtain input from engineering, manufacturing, regulatory affairs, and other relevant departments to complete the product strategic plan efficiently.
- Collaborate with sales on product support for new product launches, existing product segments, training programs, and key surgeon and account management.
- Establish and maintain relationships with designing and consulting physicians.
- Interface with managers and directors of other product lines to understand interdependent relationships between product portfolios.
- Support the Medical Education department by helping prepare and run surgeon and sales training courses, including didactic and cadaver laboratories.
- Collaborate with communications and related departments to develop promotional, advertising, and value-added services that maximize revenue for the assigned product line.
- Sales experience is a plus.
- A Master of Business Administration is preferred.
About the company
Alphatec Spine develops and sells implants, instruments, and integrated technologies for spine surgery, including devices used in fusion procedures and related navigation or imaging systems gained through acquisitions like SafeOp Surgical. During surgery, surgeons use these implants and instruments, often with imaging or navigation tools to plan and guide the procedure, while the implants support fusion and healing. It differentiates itself with a broad product portfolio and enhanced technology through strategic acquisitions, giving it capabilities in navigation and advanced spine solutions beyond a narrow line of implants. Its goal is to improve spinal surgery outcomes and expand access to effective spine-care solutions.
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Carlsbad, California
Founded
1990
Get referred to Alphatec Spine
See people who can refer or advise you
Simplify's Take
What believers are saying
- Q2 2026 revenue reached $213.5 million, up 15% year over year.
- Adjusted EBITDA rose 53% to $36 million, lifting margin to 17%.
- May 2026 refinancing extended maturities to 2031 and cut interest expense $6 million.
What critics are saying
- May 2026 EOS revenue missed expectations; installations failed, triggering a 32% stock drop.
- Kirby McInerney, Pomerantz, and others investigate potential securities fraud after the May 5 disclosure.
- With $685 million debt, another EOS stall can force dilutive financing before 2030.
What makes Alphatec Spine unique
- ATEC combines EOS imaging, Valence robotics, SafeOp neuromonitoring, and patient-specific planning.
- Tommy Carls joined September 2026 to unify InformatiX across imaging, analytics, and surgery.
- Its procedural ecosystem ties preoperative planning directly to intraoperative execution.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
Paid Vacation
Paid Sick Leave
Paid Holidays
Disability Insurance
Stock Options
Growth & Insights and Company News
6 month growth
7%1 year growth
6%2 year growth
6%ATEC appoints Tommy Carls Executive Vice President, Data Intelligence and Strategy. Accomplished spine executive to advance ATEC's InformatiX strategy CARLSBAD, Calif.-(BUSINESS WIRE)-Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced that Thomas "Tommy" Carls has joined the company as Executive Vice President, Data Intelligence and Strategy. Carls will report directly to Chairman and Chief Executive Officer, Pat Miles, and will serve as a member of ATEC's Senior Leadership Team. In this newly created role, Carls will lead ATEC's development and marketing efforts across EOSedge, EOS Insight, data acquisition and analytics, and the broader InformatiX strategy. His mandate is to focus priorities, connect global teams and capabilities, and accelerate an integrated strategy that turns information about each patient and procedure into actionable clinical insight. "I have known and trusted Tommy for nearly 30 years," said Miles. "He has spent his career translating complex clinical needs into technologies that meaningfully advance spine surgery. Tommy is a student of spine. His depth of experience across implants, enabling technologies, imaging, software and clinical strategy makes him uniquely qualified to lead this next phase of our evolution. I am confident Tommy will help us accelerate the use of data and predictive analytics to make spine surgery better informed, more reproducible and personalized." ATEC has assembled a procedural ecosystem spanning EOS imaging, EOS Insight, surgical planning, Valence navigation and robotics, SafeOp neuromonitoring, and patient-specific solutions. By connecting those capabilities through InformatiX, ATEC intends to apply data and predictive analytics to inform decisions before, during and after surgery, improve the reproducibility of surgical execution, and create a learning system that advances spine care over time. Carls brings more than 3 decades of leadership and innovation experience in spine and medical technology. Throughout his career, Carls has helped develop and launch market-leading technologies across spinal implants, enabling technologies, image-guided surgery and robotics. He previously served as Vice President of Product and Clinical at Proprio Vision, where he helped advance an artificial intelligence-enabled surgical navigation platform. Before Proprio, Carls spent more than two decades with Sofamor Danek and Medtronic in numerous executive roles, spanning engineering, product development, marketing and global research and development. He holds more than 80 patents. Carls earned a Bachelor of Science degree in mechanical engineering from Tulane University and a Master of Business Administration from the University of Memphis. "ATEC has assembled a distinctive set of technologies across imaging, procedural planning, navigation and robotics, neuromonitoring, and patient-specific solutions," Carls said. "The opportunity is to connect those capabilities and apply data and predictive analytics, so a patient-specific plan becomes a shared source of truth across the continuum of care. This will inform better decisions, improve execution and create a learning system that advances outcomes over time. I am excited to join Pat and the high-performing ATEC team, to help bring that vision to life." About Alphatec Holdings Inc. ATEC, through its wholly owned subsidiaries, Alphatec Spine, Inc., EOS imaging S.A.S. and SafeOp Surgical, Inc., is a medical device company dedicated to revolutionizing the approach to spine surgery through clinical distinction. ATEC's Organic Innovation Machine(TM) is focused on developing new approaches that integrate seamlessly with the Company's expanding InformatiX(TM) platform to better inform surgery and more safely and reproducibly achieve the goals of spine surgery. ATEC's vision is to be the Standard Bearer in Spine. For more information, visit www.atecspine.com. Forward Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. Forward-looking statements include, among other things, statements regarding the Company's strategy; the integration of its technologies, teams and capabilities; the use of data and predictive analytics; and the anticipated clinical or commercial benefits of its InformatiX platform and procedural ecosystem. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Important factors include the Company's ability to execute its strategic operating plan, develop and integrate new products and technologies, obtain and maintain regulatory clearances or approvals, achieve surgeon acceptance, protect intellectual property, manage product liability and litigation exposure, and address other risks described in the Company's most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K filed with the Securities and Exchange Commission. The Company disclaims any intention or obligation to update or revise forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Contacts. Investor and Media Contact Robert Judd Investor Relations (760) 494-6790 [email protected]
Alphatec Holdings has appointed Tommy Carls as executive vice president of data intelligence and strategy. Carls will report to chief executive officer Pat Miles and join the company's senior leadership team. In this newly created role, Carls will lead ATEC's development and marketing efforts across EOSedge, EOS Insight, data acquisition and analytics, and the broader InformatiX strategy. His focus will be connecting global teams and turning patient and procedure information into actionable clinical insight. Carls brings over 30 years of experience in spine and medical technology. He previously served as vice president of product and clinical at Proprio Vision and spent more than two decades at Sofamor Danek and Medtronic. He holds more than 80 patents.
Alphatec shares surged 19.7% to $10.58, driven by investor optimism following strong second-quarter 2026 results. The medical equipment company reported earnings per share of 7 cents and revenues of $213.5 million for the quarter. The company maintains its full-year 2026 revenue guidance of approximately $882 million, supported by strong case volume growth, increased surgeon adoption, expanding profitability and positive free cash flow generation. For the upcoming quarter, Alphatec expects earnings of $0.11 per share, representing a 266.7% year-over-year increase. Revenues are projected at $224.28 million, up 14.1% from the prior year. However, the consensus earnings estimate has remained unchanged over the past 30 days. The stock currently carries a Zacks Rank #3 (Hold).
Alphatec Holdings reported strong Q2 2026 results with total revenue of $214 million, up 15% year-over-year, and surgical revenue of $196 million, up 17%. The medical device company saw adjusted EBITDA rise 53% to $36 million, with margins expanding 420 basis points to 17%. The company added 24% more net new surgeons and posted 20% case volume growth. Gross margin improved 260 basis points to 72.5%, driven by better inventory efficiency and favourable product mix. Alphatec generated positive free cash flow of approximately $1 million in Q2 and raised full-year adjusted EBITDA guidance to $140 million from $134 million previously. However, revenue per case declined 2.7% due to case mix shifts and international growth. The company now expects full-year revenue per case to decline in the low single digits, citing slower biologics attachment improvement.
Alphatec, a spine surgery technology company, reported revenue of $764.2 million in FY 2025, up 25% year-over-year, but posted a net loss of $143.4 million. The company's debt-to-equity ratio stands at approximately 17.2x, whilst its current ratio is 2.1x. Stock-based compensation represented roughly 163% of operating cash flow. Inspire Medical Systems specialises in neurostimulation therapy for obstructive sleep apnea patients who cannot use standard breathing machines. The company targets sleep specialists and ENT surgeons globally. Alphatec differentiates itself through an integrated ecosystem using subsidiaries like EOS imaging and SafeOp Surgical, serving primarily the US hospital market whilst expanding into Europe and Japan. Both companies operate in medical technology but represent different maturity levels and financial profiles for investors seeking healthcare device exposure.